ArticleTurkish journal of pharmaceutical sciences2025
Validation and Reliability of the Turkish Version of a Patient Satisfaction Survey for Comprehensive Medication Management.
Article in Turkish journal of pharmaceutical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Comprehensive Medication Management (CMM) is pivotal in optimizing clinical outcomes through personalized medication review and patient engagement. Patient satisfaction surveys, such as the Medication Management Patient Satisfaction Survey (MMPSS), play a crucial role in assessing the quality of these services. However, there is currently no Turkish version of the MMPSS available. This study aimed to translate, culturally adapt, and validate the Turkish version of the MMPSS to assess patient satisfaction with CMM services provided by pharmacists in Türkiye. Materials and Methods: Following established guidelines for cross-cultural instrument validation, the MMPSS was translated into Turkish and culturally adapted. The survey underwent forward translation, expert panel review, back-translation, and pilot testing. Data collection occurred in a tertiary care university hospital between September 9, 2022, and March 21, 2023. Psychometric analyses included reliability testing (Cronbach's alpha), factorial validity using confirmatory factor analysis, and test-retest reliability using the Intraclass Correlation Coefficient (ICC). Results: A total of 124 participants (82.7%) completed the survey. Participants were mostly women (57.3%) and elderly, with a mean age of 70.43 years, three comorbidities, and six medications. The Turkish MMPSS demonstrated excellent internal consistency (Cronbach's α = 0.858) and test-retest reliability (ICC=0.937), confirming its reliability over time. Factor analysis supported a one-factor structure, consistent with the original MMPSS framework, and all items showed strong correlations. Conclusion: The Turkish version of the MMPSS is a reliable and valid instrument for assessing patient satisfaction with CMM services in Türkiye. Its implementation can enhance the evaluation and improvement of clinical pharmacy services, ultimately promoting better patient care and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.